V8Y Stock Overview
Engages in the design, assembly, and distribution of advanced therapeutic solutions for the minimally invasive treatment of complex vascular diseases in Singapore. More details
Snowflake Score | |
---|---|
Valuation | 4/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 2/6 |
Dividends | 0/6 |
Quantum Healthcare Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | S$0.002 |
52 Week High | S$0.003 |
52 Week Low | S$0.001 |
Beta | 0.95 |
11 Month Change | 0% |
3 Month Change | 0% |
1 Year Change | -33.33% |
33 Year Change | -75.00% |
5 Year Change | -33.33% |
Change since IPO | -99.41% |
Recent News & Updates
Recent updates
Shareholder Returns
V8Y | SG Medical Equipment | SG Market | |
---|---|---|---|
7D | 0% | -1.0% | 0.5% |
1Y | -33.3% | 1.0% | 14.1% |
Return vs Industry: V8Y underperformed the SG Medical Equipment industry which returned 1% over the past year.
Return vs Market: V8Y underperformed the SG Market which returned 14.1% over the past year.
Price Volatility
V8Y volatility | |
---|---|
V8Y Average Weekly Movement | 72.6% |
Medical Equipment Industry Average Movement | 6.8% |
Market Average Movement | 4.6% |
10% most volatile stocks in SG Market | 14.4% |
10% least volatile stocks in SG Market | 2.1% |
Stable Share Price: Data is not available.
Volatility Over Time: Insufficient data to determine V8Y's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2005 | 99 | Thomas Tan | quantumhealthcare.com.sg |
Quantum Healthcare Limited, together with its subsidiaries, engages in the design, assembly, and distribution of advanced therapeutic solutions for the minimally invasive treatment of complex vascular diseases in Singapore. It operates through Vascular Business and Healthcare Business segments. The Vascular Business segment engages in the development, manufacturing, and distribution of medical devices.
Quantum Healthcare Limited Fundamentals Summary
V8Y fundamental statistics | |
---|---|
Market cap | S$16.03m |
Earnings (TTM) | -S$1.55m |
Revenue (TTM) | S$12.67m |
1.3x
P/S Ratio-10.3x
P/E RatioIs V8Y overvalued?
See Fair Value and valuation analysisEarnings & Revenue
V8Y income statement (TTM) | |
---|---|
Revenue | S$12.67m |
Cost of Revenue | S$7.08m |
Gross Profit | S$5.58m |
Other Expenses | S$7.14m |
Earnings | -S$1.55m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -0.00019 |
Gross Margin | 44.08% |
Net Profit Margin | -12.26% |
Debt/Equity Ratio | -77.6% |
How did V8Y perform over the long term?
See historical performance and comparison